Trial Profile
Prospective Evaluation of Low-dose Irinotecan and Cyberknife Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions
- Sponsors Advocate Health Care
- 19 Jul 2021 Planned End Date changed from 1 Oct 2025 to 29 Nov 2017.
- 19 Jul 2021 Planned primary completion date changed from 1 Oct 2020 to 29 Nov 2017.
- 21 Feb 2018 Status changed from recruiting to withdrawn prior to enrolment.